Recommended Products
Assay
≥99.995%
SMILES string
[Xe]
InChI
1S/Xe
InChI key
FHNFHKCVQCLJFQ-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Packaging
pressure tin
filling pressure at 15°C: 11 bar; content (15°C, 1 bar): 11 L
filling pressure at 15°C: 11 bar; content (15°C, 1 bar): 11 L
Other Notes
Sales restrictions may apply
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Press. Gas Liquefied gas
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Acta anaesthesiologica Scandinavica, 57(5), 646-653 (2013-01-16)
Neuroprotection from therapeutic hypothermia increases when combined with the anaesthetic gas xenon in animal studies. A clinical feasibility study of the combined treatment has been successfully undertaken in asphyxiated human term newborns. It is unknown whether xenon alone would be
Nature chemistry, 5(1), 61-65 (2012-12-19)
Xenon, which is quite inert under ambient conditions, may become reactive under pressure. The possibility of the formation of stable xenon oxides and silicates in the interior of the Earth could explain the atmospheric missing xenon paradox. Using an ab
British journal of anaesthesia, 111(3), 406-416 (2013-04-13)
To date, only limited data exist about the use of xenon as an anaesthetic agent in patients undergoing cardiac surgery. The favourable cardio- and neuroprotective properties of xenon might attenuate postoperative complications, improve outcome, and reduce the incidence of delirium.
Critical care medicine, 41(9), 2116-2124 (2013-07-31)
Preclinical studies reveal the neuroprotective properties of xenon, especially when combined with hypothermia. The purpose of this study was to investigate the feasibility and cardiac safety of inhaled xenon treatment combined with therapeutic hypothermia in out-of-hospital cardiac arrest patients. An
X-ray-computed tomography contrast agents.
Chemical reviews, 113(3), 1641-1666 (2012-12-06)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service